Stemberg
Abstract
| ROB-ID was the outcome of DIH-HERO funded FSTP project. Vaccines are a world-wide success story. No less than 10 million of deaths have been avoided between 2010 and 2015 according to the World Health Organisation (WHO). Over the past few years, we’ve obviously been faced with one of the largest pandemics as the coronavirus, SARS-CoV-2, was spreading at an unstoppable pace. In Europe alone, well over 251M cases and over 2.1M deaths have been reported to date, and numbers finally have come to a halt. Global vaccine production capacity is large but limited. This means that during any pandemic, in a short time frame of f.i. 2-4 months, less than 1/6th of the population can be vaccinated. In the light of ‘Disease X’ and pandemic preparedness, the need for ensuring global vaccination coverage as well as creating sufficient manufacturing capacity is clear. This is where Robotic intradermal (ID) vaccination, i.e. vaccination in the skin, can come into play. |